Yeah, six months ago I thought Canada would do best because they ordered the most choices. In hindsight I now know they should have ordered less and instead invested in a supply chain for what they ordered. It would have been more of a gamble though. I wonder if they could have built a MRNA plant that could flex to moderna or Pfizer, and similar for the other 4 vaccine technologies (that I can't spell), even though only two are significant so far. (With promising futures for the others )
